ThermoGenesis Corp. to Announce Second Quarter Fiscal 2013 Results on February 12, 2013

ThermoGenesis Corp. to Announce Second Quarter Fiscal 2013 Results on February
12, 2013

RANCHO CORDOVA, Calif., Feb. 5, 2013 (GLOBE NEWSWIRE) -- ThermoGenesis Corp.
(Nasdaq:KOOL), a leading supplier of innovative products that process and
store adult stem cells, announced today it will report financial results for
the fiscal second quarter ended December 31, 2012, on Tuesday, February 12,
2013.

Company's Conference Call and Webcast

Management will host a conference call Tuesday, February 12, 2013 at 2:00 PM
Pacific (5:00 PM Eastern) to review the fiscal second quarter financial
results.

The call can be accessed by dialing 1-800-860-2442 within the U.S. or
1-412-858-4600 outside the U.S. and referencing, "ThermoGenesis." Mr. Matthew
T. Plavan, Chief Executive Officer will host the call to discuss the second
quarter results and other corporate events, followed by a Q&A session.
Participants are asked to call the assigned number approximately five minutes
before the conference call begins.

To listen to the audio webcast of the call during or after the event, please
visit: http://www.thermogenesis.com/investors-webcasts-and-calls.aspx.

Replay

A replay of the conference call will be available two hours after the call for
the following five business days by dialing 1-877-344-7529 within the U.S. or
1-412-317-0088 outside the U.S. and entering the following account number when
prompted '385107'.

About ThermoGenesis Corp.

ThermoGenesis Corp. (www.thermogenesis.com) is a leading supplier of
innovative products and services that process and store adult stem cells for
treatment of disease and injury.

The ThermoGenesis Corp. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=14120

   This press release contains forward-looking statements.These statements
  involve risks and uncertainties that could cause actual outcomes to differ
materially from those contemplated by the forward-looking statements. Several
 factors including timing of FDA and foreign regulatory approvals, changes in
customer forecasts, our failure to meet customers' purchase order and quality
requirements, supply shortages, production delays, changes in the markets for
 customers' products, introduction timing and acceptance of our new products
 scheduled for fiscal year 2013, and introduction of competitive products and
   other factors beyond our control could result in a materially different
revenue outcome and/or in our failure to achieve the revenue levels we expect
  for fiscal 2013.A more complete description of these and other risks that
    could cause actual events to differ from the outcomes predicted by our
 forward-looking statements is set forth under the caption "Risk Factors" in
 our annual report on Form 10-K and other reports we file with the Securities
  and Exchange Commission from time to time, and you should consider each of
        those factors when evaluating the forward-looking statements.

                    Web site: http://www.thermogenesis.com

CONTACT: Investor Relations
         +1-916-858-5107, or
         Email: ir@thermogenesis.com

ThermoGenesis Corp. Logo
 
Press spacebar to pause and continue. Press esc to stop.